杏輝

+0.05 (+0.16%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

31.20130成交張數16.86本益比1.72股價淨值比5.13%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度	單季 EPS	年增	近四季 EPS	歸屬母公司淨利(億)	淨利率	ROE(季)	ROE(近四季)
2026Q2	0.45	32.6%	1.73	0.93	10.6%	2.65%	10.58%
2026Q1	0.37	-34.0%	1.62	0.74	8.9%	2.11%	9.45%
2025Q4	0.50	23.7%	1.81	1.02	11.6%	3.02%	10.91%
2025Q3	0.41	78.1%	1.72	0.83	9.6%	2.56%	10.65%
2025Q2	0.34	5.3%	1.53	0.68	8.4%	2.07%	9.81%
2025Q1	0.56	1.5%	1.52	1.12	14.0%	3.38%	9.28%
2024Q4	0.40	-26.3%	1.51	0.82	9.6%	2.54%	9.58%
2024Q3	0.23	-38.1%	1.65	0.48	6.3%	1.51%	10.72%
2024Q2	0.32	-40.0%	1.80	0.65	8.4%	2.05%	11.94%
2024Q1	0.55	37.5%	2.01	1.10	14.2%	3.49%	13.00%
2023Q4	0.55	843.1%	1.86	1.10	14.7%	3.59%	12.45%
2023Q3	0.37	12.5%	1.37	0.76	10.6%	2.56%	9.30%
2023Q2	0.54	25.0%	1.33	1.09	15.0%	3.67%	9.29%
2023Q1	0.40	37.1%	1.22	0.80	10.4%	2.70%	8.47%
2022Q4	0.06	–	1.11	0.11	1.5%	0.39%	7.95%
2022Q3	0.33	–	0.98	0.68	9.6%	2.36%	7.02%
2022Q2	0.43	1636.9%	0.48	0.87	12.2%	3.08%	3.46%
2022Q1	0.29	1064.4%	0.07	0.58	8.7%	2.10%	0.55%
2021Q4	-0.07	–	-0.19	-0.15	-2.3%	-0.55%	-1.40%
2021Q3	-0.17	–	-0.38	-0.33	-5.9%	-1.22%	-2.84%
2021Q2	0.02	-40.1%	-0.27	0.05	0.9%	0.20%	-1.97%
2021Q1	0.03	-81.2%	-0.25	0.05	0.8%	0.19%	-1.84%
2020Q4	-0.27	-260.1%	-0.14	-0.54	-10.0%	-1.99%	-1.03%
2020Q3	-0.05	–	0.29	-0.10	-1.5%	-0.36%	2.21%
2020Q2	0.04	–	0.29	0.09	1.5%	0.31%	2.15%
2020Q1	0.13	77.7%	0.12	0.27	4.3%	0.96%	0.92%
2019Q4	0.17	399.4%	0.07	0.35	5.2%	1.25%	0.49%
2019Q3	-0.05	–	-0.07	-0.10	-1.8%	-0.36%	-0.46%
2019Q2	-0.12	–	-0.08	-0.25	-4.3%	-0.85%	-0.58%
2019Q1	0.07	-10.0%	0.03	0.14	2.5%	0.49%	0.21%
2018Q4	0.03	-69.2%	0.04	0.08	1.3%	0.26%	0.29%
2018Q3	-0.07	-188.9%	0.12	-0.14	-2.7%	-0.48%	0.78%
2018Q2	-0.01	-120.0%	0.26	-0.01	-0.3%	-0.04%	1.70%
2018Q1	0.08	–	0.31	0.17	3.0%	0.54%	2.03%
2017Q4	0.11	-48.0%	0.18	0.22	3.9%	0.72%	1.19%
2017Q3	0.07	–	0.28	0.14	2.6%	0.46%	1.83%
2017Q2	0.04	–	0.18	0.09	1.8%	0.31%	1.17%
2017Q1	-0.04	–	0.12	-0.09	-1.7%	-0.29%	0.78%
2016Q4	0.21	–	0.08	0.42	7.0%	1.35%	–
2016Q3	-0.03	–	–	-0.06	-1.2%	-0.20%	–